Here are five things to know:
1. The report looks at vaccines, pharmaceuticals and technologies for deliveries of therapeutics.
2. Nanotechnology in virology is featured, as well as systemic delivery of antiviral agents and vaccines.
3. The report provides a SWOT analysis of antiviral approaches.
4. Profiles of 188 companies that develop technologies are included.
5. Pharmaceutical, biopharmaceutical, antiviral drug and viral vaccine companies are analyzed.
More articles on quality & infection control:
The ASC infection control manifesto: 4 essentials for survey readiness
Extension Healthcare awarded for alarm safety software: 5 points
NIH study to combat RSV infection — 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
